by Vaibhav Rastogi, MBBS; Lauren L. Donnangelo; Ganesh Asaithambi, MD; Sharatchandra Bidari, MD; Anna Y. Khanna, MD; and Vishnumurthy Shushrutha Hedna, MD Drs. Rastogi, Asaithambi, Khanna, and Hedna and Ms.
by Shahid Ali, MD; Shagufta Jabeen, MD; Rebecca J. Pate, MD; Marwah Shahid, MS; Sandhya Chinala, MD; Milankumar Nathani, MD; and Rida Shah, MD Drs. Ali, Chinala, Nathani, and Shah
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine
by Muruga A. Loganathan, MD; Manasa Enja, MD; and Steven Lippmann, MD Dr. Loganathan is a resident in the Department of Psychiatry, Allegheny General Hospital, Pittsburgh, Pennsylvania; Dr. Enja is
Dear Editor: Multiple sclerosis (MS) is a relatively frequent inflammatory autoimmune illness of the central nervous system affecting about 2.5 million people around the world and representing the most common
Dear Editor: Atypical long-acting injectable (LAI) antipsychotics may improve treatment options for patients with serious mental illnesses, such as schizophrenia and bipolar disorder.[1] A systematic review of 1,700 outpatients from
